Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?
作者信息
Phillips Kathryn A, Marshall Deborah A, Kurian Allison W
机构信息
UCSF Center for Translational & Policy Research on Personalized Medicine (TRANSPERS), Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA.
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143, USA.
出版信息
Per Med. 2019 Sep;16(5):365-367. doi: 10.2217/pme-2019-0045. Epub 2019 Sep 25.
Abstract
摘要
相似文献
1
Can precision medicine help achieve the goal of reducing care when the risks exceed the benefits?当风险超过益处时，精准医学能否有助于实现减少医疗护理的目标？
Per Med. 2019 Sep;16(5):365-367. doi: 10.2217/pme-2019-0045. Epub 2019 Sep 25.
2
Precision medicine: what's all the fuss about?精准医学：究竟在大惊小怪些什么？
Scand J Clin Lab Invest Suppl. 2016;245:S2-5. doi: 10.1080/00365513.2016.1206434. Epub 2016 Aug 17.
3
Update: healthcare reform - it's getting personal.最新消息：医疗改革——正变得与个人息息相关。
Per Med. 2017 Jul;14(4):281-283. doi: 10.2217/pme-2017-0026. Epub 2017 Jun 22.
4
Health Economics Tools and Precision Medicine: Opportunities and Challenges.卫生经济学工具与精准医学：机遇与挑战。
Forum Health Econ Policy. 2020 Mar 5;23(1):fhep-2019-0013. doi: 10.1515/fhep-2019-0013.
5
Translating genomics in cancer care.癌症诊疗中的基因组学翻译。
J Natl Compr Canc Netw. 2013 Nov;11(11):1343-53. doi: 10.6004/jnccn.2013.0158.
6
From personalized medicine to personalized science: uniting science and medicine for patient-driven, goal-oriented research.从个性化医学到个性化科学：将科学和医学联合起来，进行以患者为驱动、以目标为导向的研究。
Rejuvenation Res. 2013 Oct;16(5):414-8. doi: 10.1089/rej.2013.1471.
7
Personalized medicine should not be restricted to the wealthy.个性化医疗不应局限于富人。
Nature. 2018 Jul;559(7712):32. doi: 10.1038/d41586-018-05609-9.
8
Precision Medicine from a Public Health Perspective.从公共卫生角度看精准医学。
Annu Rev Public Health. 2018 Apr 1;39:153-168. doi: 10.1146/annurev-publhealth-040617-014158. Epub 2017 Nov 20.
9
Balancing the Economics and Ethics of Personalised Oncology.平衡个性化肿瘤学的经济学与伦理学
Trends Cancer. 2018 Sep;4(9):608-615. doi: 10.1016/j.trecan.2018.07.006. Epub 2018 Aug 17.
10
Personalized medicine in psychiatry: ethical challenges and opportunities.精神病学中的个性化医疗：伦理挑战与机遇。
Dialogues Clin Neurosci. 2009;11(4):427-34. doi: 10.31887/DCNS.2009.11.4/kevers.
本文引用的文献
1
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.基于 21 基因表达检测的乳腺癌辅助化疗。
N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.
2
Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.近期化疗应用趋势及肿瘤学家对早期乳腺癌的治疗推荐。
J Natl Cancer Inst. 2018 May 1;110(5):493-500. doi: 10.1093/jnci/djx239.
3
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay.70 基因签名检测结果与 21 基因检测为中危的早期乳腺癌患者医生治疗指导的相关性。
JAMA Oncol. 2018 Jan 11;4(1):e173470. doi: 10.1001/jamaoncol.2017.3470.
4
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.在重症监护病房对婴儿使用外显子组测序：严重单基因疾病的确诊及对医疗管理的影响
JAMA Pediatr. 2017 Dec 4;171(12):e173438. doi: 10.1001/jamapediatrics.2017.3438.
5
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.基于早期乳腺癌基因表达谱的化疗治疗决策中，女性如何权衡收益与风险？一项离散选择实验。
BMJ Open. 2016 Jun 2;6(6):e010981. doi: 10.1136/bmjopen-2015-010981.
6
Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care.大多数美国人不相信医疗保健价格与医疗质量之间存在关联。
Health Aff (Millwood). 2016 Apr;35(4):647-53. doi: 10.1377/hlthaff.2015.1334.
7
Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology.消费者对个性化医疗的熟悉程度、看法及预期价值，重点关注肿瘤学中的应用。
Per Med. 2015 Jan 1;12(1):13-22. doi: 10.2217/pme.14.74.
8
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.个体化医学的应用：影响乳腺癌治疗中基因表达谱应用和价值的因素。
Curr Oncol. 2014 Jun;21(3):e426-33. doi: 10.3747/co.21.1782.
9
Is there a kink in consumers' threshold value for cost-effectiveness in health care?消费者在医疗保健方面对成本效益的阈值是否存在拐点？
Health Econ. 2002 Mar;11(2):175-80. doi: 10.1002/hec.655.
Zotero 插件